Aethlon Medical Inc. (AEMD) intrinsic value & 10-year financials
Aethlon Medical Inc. (AEMD) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $5.15
- Market cap
- $3.5M
- Revenue (FY2026)
- —
- Revenue growth (10-yr CAGR)
- 6.6%
- ROIC (10-yr avg)
- -222.5%
- Free cash flow (FY2026)
- -$7.0M
AEMD 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2026 | — | -$7.2M | -$10.61 | -$7.0M | — | 8050.4% |
| FY2025 | — | -$13.4M | -$8.58 | -$7.6M | — | -2002.2% |
| FY2024 | $0 | -$12.2M | -$4.86 | -$10.4M | — | -1033.7% |
| FY2023 | $574.2K | -$12.0M | -$0.59 | -$11.4M | -2072.0% | -1115.1% |
| FY2022 | $294.2K | -$10.4M | -$0.71 | -$10.1M | -3542.5% | -8974.9% |
| FY2021 | $659.1K | -$7.9M | — | -$6.8M | -1197.1% | 2703.6% |
| FY2020 | $650.2K | -$6.4M | — | -$5.3M | -912.0% | 762.4% |
| FY2019 | $229.6K | -$6.2M | — | -$4.3M | -2612.5% | 427.6% |
| FY2018 | $149.6K | -$5.7M | — | -$3.9M | -3228.8% | -141.9% |
| FY2017 | $392.1K | -$7.3M | — | -$3.5M | -1555.4% | -901.6% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
AETHLON MEDICAL INC revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
AETHLON MEDICAL INC has historically struggled to out-earn its cost of capital, averaging just -16.3% ROIC.
AETHLON MEDICAL INC capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, AETHLON MEDICAL INC is modeled at 6.6% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-198.09 per share.